Pegasus Tech Ventures, a prominent San Jose-based venture capital firm, has announced a new corporate venture capital (CVC) fund in partnership with CYBERDYNE Inc. The JPY 10 billion, or $60 million, fund is dedicated to advancing startups in high-growth technology sectors. This strategic collaboration will focus on robotics, physical AI, healthcare, and intelligent systems, aligning with CYBERDYNE's innovative vision for the future of human-machine integration.
A Strategic Alliance for Technological Advancement
The new fund establishes a clear partnership structure, with Pegasus Tech Ventures acting as the general partner and CYBERDYNE participating as the sole limited partner. This arrangement allows CYBERDYNE to leverage Pegasus's extensive Venture Capital-as-a-Service (VCaaS) platform and global network. The collaboration is designed to identify and nurture startups developing technologies that support CYBERDYNE’s concept of a “human-cyber-physical space” (HCPS) cybernics.
Pegasus's Role as an Innovation Catalyst
For over a decade, Pegasus Tech Ventures has successfully connected corporations in Asia with the innovation hubs of Silicon Valley and other global ecosystems. The firm manages over $2 billion in assets across more than 40 funds, demonstrating its significant influence in the venture capital landscape. Its portfolio includes investments in groundbreaking companies such as SpaceX, OpenAI, and Airbnb, showcasing a strong track record of identifying transformative technologies.
Through its VCaaS model, Pegasus provides corporate partners with unparalleled access to promising technology companies and strategic investment opportunities. Dr. Anis Uzzaman, founder and CEO of Pegasus, highlighted the growing importance of robotics and intelligent systems in solving global challenges. He expressed enthusiasm for connecting CYBERDYNE with entrepreneurs and technologies that align with its long-term strategic goals and vision.
CYBERDYNE's Pioneering Work in Cybernics
Founded in 2004, CYBERDYNE has established itself as a leader in cybernics, a field that merges human biology with technology to enhance physical and cognitive functions. The company's flagship product, the Hybrid Assistive Limb (HAL), exemplifies this by responding to the wearer's bioelectric signals. This innovative assistive device has seen widespread adoption in medical, healthcare, and industrial applications both in Japan and internationally.
This partnership with Pegasus is a strategic move for CYBERDYNE to expand its global reach and collaborate with emerging innovation ecosystems. The company aims to address pressing societal issues, including the challenges posed by aging populations, labor shortages, and rising healthcare demands. By investing in synergistic startups, CYBERDYNE seeks to accelerate the development of solutions that can create significant societal value.
A Shared Vision for Global Impact
Both organizations share a commitment to fostering innovation that creates new value by fusing humans, AI-robotics, and information systems. Yoshiyuki Sankai, founder and CEO of CYBERDYNE, stated that the partnership will accelerate technology development, business co-creation, and global expansion. The collaboration is poised to unlock new opportunities in emerging sectors by combining CYBERDYNE's domain expertise with Pegasus's investment acumen.
The launch of this $60 million CVC fund marks a significant milestone for both Pegasus Tech Ventures and CYBERDYNE, promising to fuel the next wave of innovation. By strategically investing in startups focused on robotics, AI, and healthcare, the partnership is well-positioned to advance the field of cybernics. Ultimately, this collaboration aims to leverage breakthrough technologies to address critical global challenges and shape a more integrated future for humanity and machines.